Lynwood Capital Management »

Madrigal Pharmaceuticals shares owned by Lynwood Capital Management

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Lynwood Capital Management from 13F filings

Historical chart of Lynwood Capital Management investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Lynwood Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Lynwood Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $730k 5.0k 146.04

More positions owned by Lynwood Capital Management

Briacell Therapeutics Corp
Americas Gold And Silver Cor (USAS)
Vaneck Etf Trust Gold Miners Etf (GDX)
Altimmune Com New (ALT)
Immix Biopharma (IMMX)
Advanced Micro Devices (AMD)
Teck Resources CL B (TECK)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Spire Global Com Cl A New (SPIR)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Vermilion Energy (VET)
Lightspeed Commerce Sub Vtg Shs (LSPD)
Diamond Offshore Drilli (DO)
Mag Silver Corp
Transocean Registered Shs (RIG)

View all positions for Lynwood Capital Management

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Rtw Investments
Paulson & Co
Henderson Group
venBio Select Advisor
Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
William Blair Investment Management
Wellington Management Company
FMR
Goldman Sachs Group
Susquehanna International
Invesco

View all funds holding Madrigal Pharmaceuticals